These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7542409

  • 21. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M, Jardi R, Rodriguez-Frias F, Allende H, Cotrina M, Esteban R, Guardia J.
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [Abstract] [Full Text] [Related]

  • 22. [Treatment with interferon in chronic hepatitis. General Subdirectorate of Services and Evaluation of Health Technologies, General Directorate of Assurance and Health Planning, Ministry of Health and Consumption].
    Med Clin (Barc); 1994 Oct 22; 103(13):498-504. PubMed ID: 7527884
    [No Abstract] [Full Text] [Related]

  • 23. [Antiviral treatment of chronic hepatitis B].
    Bourel M, Brissot P.
    Rev Prat; 1987 Apr 21; 37(23):1353-7. PubMed ID: 2440096
    [No Abstract] [Full Text] [Related]

  • 24. [Treatment of hepatitis B].
    Telegdy L.
    Orv Hetil; 2004 Nov 07; 145(45):2293-6. PubMed ID: 15573894
    [Abstract] [Full Text] [Related]

  • 25. [Predictive factors of response to interferon in chronic hepatitis].
    Forns X, Ampurdanés S.
    Gastroenterol Hepatol; 1995 Nov 07; 18(7):388-95. PubMed ID: 7553278
    [No Abstract] [Full Text] [Related]

  • 26. [The cost-benefit of interferon therapy in chronic viral liver diseases].
    Ascione A, De Luca M.
    Minerva Gastroenterol Dietol; 1995 Mar 07; 41(1):123-5. PubMed ID: 7542483
    [No Abstract] [Full Text] [Related]

  • 27. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A, Nishiguchi S, Shiomi S, Hayashi T, Kobayashi S, Habu D, Takeda T, Seki S, Hirohashi K, Tanaka H, Kubo S.
    Am J Gastroenterol; 2005 Aug 07; 100(8):1748-53. PubMed ID: 16086711
    [Abstract] [Full Text] [Related]

  • 28. Hepatitis B virus precore/core variation and interferon therapy.
    Fattovich G, McIntyre G, Thursz M, Colman K, Giuliano G, Alberti A, Thomas HC, Carman WF.
    Hepatology; 1995 Nov 07; 22(5):1355-62. PubMed ID: 7590647
    [Abstract] [Full Text] [Related]

  • 29. [Treatment of chronic hepatitis B].
    Carreño V, Montaño L, Torres M.
    Rev Clin Esp; 1983 Oct 15; 171(1):73-6. PubMed ID: 6197728
    [No Abstract] [Full Text] [Related]

  • 30. Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan.
    Kobayashi M, Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Someya T, Matsuda M, Sato J, Takagi K, Miyakawa Y, Kumada H.
    J Med Virol; 2002 Dec 15; 68(4):522-8. PubMed ID: 12376960
    [Abstract] [Full Text] [Related]

  • 31. [Indications for interferon therapy in hepatology].
    Eisenburg J.
    Fortschr Med; 1993 Apr 10; 111(10):157-9. PubMed ID: 7684014
    [No Abstract] [Full Text] [Related]

  • 32. Viral hepatitis.
    Lever AM, Thomas HC.
    Practitioner; 1986 Sep 10; 230(1419):751. PubMed ID: 2433683
    [No Abstract] [Full Text] [Related]

  • 33. [Cytokines and hepatitis].
    Degos F.
    Rev Prat; 1993 Mar 01; 43(5):569-73. PubMed ID: 7688135
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment.
    Teuber G, Dienes HP, Meyer zum Büschenfelde KH, Gerken G.
    Hepatogastroenterology; 1995 Apr 01; 42(2):189-91. PubMed ID: 7672771
    [Abstract] [Full Text] [Related]

  • 35. Practical therapeutics therapy for chronic hepatitis.
    Mwaungulu GS.
    East Afr Med J; 1982 Nov 01; 59(11):705-10. PubMed ID: 6191941
    [No Abstract] [Full Text] [Related]

  • 36. [Report on interferon treatment in chronic hepatitis. Office of the General Deputy Director of Benefits and Evaluation of Health Technologies. Office of the General Director of Insurance and Health Planning].
    Gastroenterol Hepatol; 1995 Jan 01; 18(1):33-41. PubMed ID: 7542554
    [No Abstract] [Full Text] [Related]

  • 37. [Chronic viral hepatitis: diagnosis and treatment].
    Stazi F, Farello P, Stazi C.
    Clin Ter; 1996 Mar 01; 147(3):85-92. PubMed ID: 8767973
    [Abstract] [Full Text] [Related]

  • 38. [The role of interferon therapy in patients with chronic hepatitis].
    Papa MZ, Halperin Z, Bar Meir S.
    Harefuah; 1981 Jul 01; 101(1-2):27-8. PubMed ID: 6172325
    [No Abstract] [Full Text] [Related]

  • 39. Pilot study of ribavirin and interferon-beta for chronic hepatitis B.
    Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y.
    Hepatology; 1993 Aug 01; 18(2):258-63. PubMed ID: 8340055
    [Abstract] [Full Text] [Related]

  • 40. Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice.
    Dumortier J, Schönig K, Oberwinkler H, Löw R, Giese T, Bujard H, Schirmacher P, Protzer U.
    Gene Ther; 2005 Apr 01; 12(8):668-77. PubMed ID: 15647761
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.